IRF3 inhibitor therapy(Jnana Therapeutics Inc)

N/A

Report date: 2025/10/20 14:18:44
NME

Base Information

Drug NameIRF3 inhibitor therapy(Jnana Therapeutics Inc)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionInterferon Regulatory Factor 3 inhibitors
TargetsInterferon Regulatory Factor 3
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJnana Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJnana Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A